SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318154-24-000011
Filing Date
2024-02-14
Accepted
2024-02-14 16:23:32
Documents
172
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amgn-20231231.htm   iXBRL 10-K 3754954
2 DESCRIPTION OF SECURITIES exhibit433-descriptionofse.htm EX-4.33 232230
3 FORM OF GRANT OF STOCK OPTION AGREEMENT exhibit102-formofgrantofst.htm EX-10.2 270222
4 FORM OF RESTRICTED STOCK UNIT AGREEMENT exhibit103-formofrestricte.htm EX-10.3 275058
5 FORM OF PERFORMANCE UNIT AGREEMENT exhibit105-formofperforman.htm EX-10.5 257439
6 AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM exhibit106-2009directorequ.htm EX-10.6 50851
7 FIFTH AMENDMENT TO SUPPLEMENTAL RETIREMENT PLAN exhibit1095-fifthamendment.htm EX-10.9 5 5680
8 FOURTH AMENDMENT TO NONQUALIFIED DEFERRED COMPENSATION PLAN exhibit10124-fourthamendme.htm EX-10.12 4 4535
9 AGREEMENT BETWEEN AMGEN INC. AND JAMES BRADNER exhibit1014-agreementbetwe.htm EX-10.14 73583
10 COLLABORATION AND LICENSE AGREEMENT BETWEEN AMGEN INC. AND CELLTECH R&D LIMITED exhibit1017-collaborationa.htm EX-10.17 1782514
11 AMENDMENT NO 2 TO CELLTECH COLLABORATION AND LICENSE AGREEMENT exhibit10171-amendmentno2t.htm EX-10.17 1 31614
12 LETTER AGREEMENT RE FTE RATES exhibit10225-letteragreeme.htm EX-10.22 5 14986
13 SUBSIDIARIES OF THE COMPANY amgn-ex21_2023.htm EX-21 30192
14 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_20231231x10k.htm EX-31 19856
15 SECTION 1350 CERTIFICATIONS amgn-ex32_20231231x10k.htm EX-32 9555
16 POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION exhibit97-policyonrecovery.htm EX-97 23391
22 GRAPHIC amgenlogo.jpg GRAPHIC 47602
23 GRAPHIC amgenlogo1.jpg GRAPHIC 47602
24 GRAPHIC amgenlogoa.jpg GRAPHIC 47602
25 GRAPHIC amgn-20231231_g1.jpg GRAPHIC 167843
26 GRAPHIC amgn-20231231_g2.jpg GRAPHIC 179905
27 GRAPHIC image_011a.jpg GRAPHIC 31874
28 GRAPHIC image_012a.jpg GRAPHIC 31874
29 GRAPHIC image_01a.jpg GRAPHIC 31874
30 GRAPHIC image_1a.jpg GRAPHIC 9930
  Complete submission text file 0000318154-24-000011.txt   23081937

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20231231.xsd EX-101.SCH 118693
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20231231_cal.xml EX-101.CAL 139860
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20231231_def.xml EX-101.DEF 776114
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20231231_lab.xml EX-101.LAB 1363434
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20231231_pre.xml EX-101.PRE 1078335
173 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20231231_htm.xml XML 3089943
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37702 | Film No.: 24638830
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)